Drugmaker Xeris Biopharma Holdings is moving its Chicago headquarters to larger digs in Fulton Market, consolidating its office and lab space in what could be a pivotal deal in the city’s efforts to attract more life sciences companies.
Drugmaker Xeris Biopharma Holdings is moving its Chicago headquarters to larger digs in Fulton Market, consolidating its office and lab space in what could be a pivotal deal in the city’s efforts to attract more life sciences companies.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In